- Lung microenvironment
- Drug development
Accepting applications from PhD students.
Mark Jones received his medical degree in 2006 from the University of Southampton, graduating with distinction in medical sciences, distinction in clinical sciences, and honours. He trained in general medicine and was awarded an NIHR Academic Clinical Fellowship in Respiratory Medicine where he developed a sub-speciality interest in the diagnosis and management of patients with interstitial lung diseases. He was then awarded a Wellcome Trust Clinical Research Training Fellowship at the University of Southampton, undertaking a PhD with Professors Donna Davies and Luca Richeldi to investigate early mechanisms of lung fibrosis and where he developed interests in human relevant in vitro models of fibrosis and the application of novel technologies to advance understanding of human lung fibrosis. Following the award of an NIHR Academic Clinical Lectureship he established the routine biobanking of samples from patients undergoing surgical lung biopsy for the investigation of fibrotic interstitial lung disease, forming a longitudinal cohort of patients which supported the establishment of the Southampton Lung Fibrosis Group, a multidisciplinary group of investigators studying determinants of progressive fibrotic lung diseases with the aims of developing novel approaches to disease classification, prognostic stratification, and treatment.